Sitagliptin

Sitagliptin is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about sitagliptin automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain sitagliptin, including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - sitagliptin

Audience:
       

(Medicine)
31 May 2016 More than one type of medicine may be necessary to control blood glucose levels in people with type 2 diabetes. View our table of combination medicines used to control blood sugar levels.
(Medicine)
31 May 2016 Gliptins is the nickname given a group of medicines called dipeptidyl peptidase-4 inhibitors. Sitagliptin, vildagliptin and saxagliptin control blood glucose levels in people with type 2 diabetes. Find out more about the benefits and side effects of gliptins.
(Medicine)
16 Sep 2015 Januvia Tablets is a brand of medicine containing the active ingredient sitagliptin. Find out about side effects, who can take it and who shouldn’t use Januvia Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Consumer publication)
04 Apr 2013 Find out all about sitagliptin with simvastatin (brand name Juvicor), a new combination medicine for people with type 2 diabetes and high cholesterol.
For health professionals (Health professional publication)
01 Jul 2011 Information on gliptins (sitagliptin, vildagliptin and saxagliptin) as add-on therapy with metformin or sulfonylurea for improved glycaemic control in type 2 diabetes.
(Consumer publication)
20 Aug 2010 This Medicine Update is for people who are taking, or thinking about taking, sitagliptin for type 2 diabetes.Medicine Update is for people who are taking, or thinking about taking, vildagliptin for type 2 diabetes.
For health professionals (Health professional publication)
01 Aug 2010 Gliptins improve glycaemic control in combination with metformin or a sulfonylurea, but their effect on diabetes-related complications and mortality is unknown.
For health professionals (Health professional publication)
01 Apr 2010 Cases of acute pancreatitis have been reported with sitagliptin and sitagliptin with metformin.
For health professionals (Health professional publication)
01 Aug 2009 Sitagliptin with metformin fixed-dose combination tablets (Janumet) have been PBS listed for the treatment of type 2 diabetes.

Medicine brands that contain sitagliptin